FBAFX | VGSTX | FBAFX / VGSTX | |
Total Expense Ratio | 0.34 | 0.30 | 113% |
Annual Report Gross Expense Ratio | 0.34 | 0.30 | 113% |
Fund Existence | 5 years | 40 years | - |
Gain YTD | 4.578 | 4.803 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 247B | 22.3B | 1,108% |
Annual Yield % from dividends | 2.14 | 2.25 | 95% |
Returns for 1 year | 5.57 | 2.57 | 217% |
Returns for 3 years | 34.68 | 16.88 | 206% |
Returns for 5 years | N/A | 11.33 | - |
Returns for 10 years | N/A | 26.71 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 106.39 | -0.56 | -0.52% |
Franklin Biotechnology Discovery C | |||
EIFVX | 19.74 | -0.19 | -0.95% |
Eaton Vance Focused Value Opps I | |||
QIACX | 48.39 | -0.63 | -1.29% |
Federated Hermes MDT All Cap Core IS | |||
CFMVX | 23.61 | -0.35 | -1.46% |
Commerce MidCap Value | |||
NBGAX | 59.39 | -1.05 | -1.74% |
Neuberger Berman Genesis Adv |